Invivyd (IVVD) stock rises as FDA aligns on LIBERTY Phase 3 trial for the company's antibody therapy VYD2311 in COVID prevention.
https://seekingalpha.com/news/4546213-invivyd-rises-fda-agrees-with-covid-trial
Invivyd (IVVD) stock rises as FDA aligns on LIBERTY Phase 3 trial for the company's antibody therapy VYD2311 in COVID prevention.
https://seekingalpha.com/news/4546213-invivyd-rises-fda-agrees-with-covid-trial
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.